Triglyceride–glucose index as a metabolic risk marker for adverse outcomes after coronary artery bypass grafting: a systematic review and meta-analysis

Yuhan Zhang, Yifan Zeng, Yirui Ning, Huiyu Wang, Xinwu Yang, Xiaobo Liao, Zhiyuan Zhang

Open source

DOI
10.3389/fendo.2026.1909829
Published
2026-09-11
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1909829,
  title = {Triglyceride–glucose index as a metabolic risk marker for adverse outcomes after coronary artery bypass grafting: a systematic review and meta-analysis},
  author = {Yuhan Zhang and Yifan Zeng and Yirui Ning and Huiyu Wang and Xinwu Yang and Xiaobo Liao and Zhiyuan Zhang},
  year = {2026},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2026.1909829},
  url = {https://doi.org/10.3389/fendo.2026.1909829}
}

RIS

TY  - JOUR
TI  - Triglyceride–glucose index as a metabolic risk marker for adverse outcomes after coronary artery bypass grafting: a systematic review and meta-analysis
AU  - Yuhan Zhang
AU  - Yifan Zeng
AU  - Yirui Ning
AU  - Huiyu Wang
AU  - Xinwu Yang
AU  - Xiaobo Liao
AU  - Zhiyuan Zhang
PY  - 2026
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1909829
UR  - https://doi.org/10.3389/fendo.2026.1909829
ER  - 

APA

Zhang, Y., Zeng, Y., Ning, Y., Wang, H., Yang, X., Liao, X., & Zhang, Z. (2026). Triglyceride–glucose index as a metabolic risk marker for adverse outcomes after coronary artery bypass grafting: a systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1909829

Source records